Home > Journals > Journal of Neurosurgical Sciences > Past Issues > Journal of Neurosurgical Sciences 2019 August;63(4) > Journal of Neurosurgical Sciences 2019 August;63(4):458-67

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Journal of Neurosurgical Sciences 2019 August;63(4):458-67

DOI: 10.23736/S0390-5616.16.03874-1

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature

Salvatore GRISANTI 1 , Vittorio D. FERRARI 1, Michela BUGLIONE 2, Giorgio M. AGAZZI 1, Roberto LISERRE 3, Luigi POLIANI 4, Luciano BUTTOLO 5, Stefano GIPPONI 6, Rebecca PEDERSINI 1, Francesca CONSOLI 1, Pierpaolo PANCIANI 5, Elisa ROCA 1, Giannantonio SPENA 5, Luca TRIGGIANI 2, Alfredo BERRUTI 1, on behalf of the Gruppo Neuro-Oncologico Bresciano

 

ACCESS OPTIONS

You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of  € 45,00.

Downloading and printing for personal use allowed.

Regain access


Access as an individual subscriber


Access through your institution

Subscribe to Journal of Neurosurgical Sciences


Recommend to your librarian


Member access

top of page